FibroGen
FGEN
HK$2.04
Share price
4.24%
Change (1 day)
-82.74%
Change (1 year)
Categories
Revenue for FibroGen (FGEN)
Revenue in 2024 (TTM): HK$0.23 Billion
According to FibroGen's latest financial reports the company's current revenue (TTM 
) is HK$0.22 Billion. a decrease over the revenue in the year 2023 that were of HK$1.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for FibroGen from 2014 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$0.22 B | -80.07% |
| 2023 | HK$1.15 B | 4.94% |
| 2022 | HK$1.09 B | -40.07% |
| 2021 | HK$1.83 B | 34.24% |
| 2020 | HK$1.36 B | -31.6% |
| 2019 | HK$1.99 B | 19.82% |
| 2018 | HK$1.66 B | 49.51% |
| 2017 | HK$1.11 B | -19.9% |
| 2016 | HK$1.39 B | -0.64% |
| 2015 | HK$1.40 B | 31.32% |
| 2014 | HK$1.06 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | HK$33.93 B | 14,660.30% | 🇺🇸 USA |
 | HK$0.87 B | 280.70% | 🇺🇸 USA |
 | HK$90.78 M | -60.51% | 🇺🇸 USA |